Skip to main content

Advertisement

Log in

Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin

  • CE - ORIGINAL
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

Fever of unknown origin (FUO) is a rather rare clinical syndrome representing a major diagnostic challenge. The occurrence of more than three febrile attacks with fever-free intervals of variable duration during 6 months of observation has recently been proposed as a subcategory of FUO, Recurrent FUO (RFUO). A substantial number of patients with RFUO have auto-inflammatory genetic fevers, but many patients remain undiagnosed. We hypothesize that this undiagnosed subgroup may be comprised of, at least in part, a number of rare genetic febrile diseases such as Fabry disease. We aimed to identify key features or potential diagnostic clues for Fabry disease as a model of rare genetic febrile diseases causing RFUO, and to develop diagnostic guidelines for RFUO, using Fabry disease as an example of inserting other rare diseases in the existing FUO algorithms. An international panel of specialists in recurrent fevers and rare diseases, including internists, infectious disease specialists, rheumatologists, gastroenterologists, nephrologists, and medical geneticists convened to review the existing diagnostic algorithms, and to suggest recommendations for arriving at accurate diagnoses on the basis of available literature and clinical experience. By combining specific features of rare diseases with other diagnostic considerations, guidelines have been designed to raise awareness and identify rare diseases among other causes of FUO. The proposed guidelines may be useful for the inclusion of rare diseases in the diagnostic algorithms for FUO. A wide spectrum of patients will be needed to validate the algorithm in different clinical settings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

α-GAL:

α-Galactosidase enzyme

CAPS:

Cryopyrin-associated periodic syndrome

CRP:

C-reactive protein

FCAS:

Familial cold urticaria (or familial cold auto-inflammatory syndrome

FD:

Fabry disease

FDG-PET:

Fluorodeoxyglucose-positron emission tomography

FMF:

Familial Mediterranean fever

FUO:

Fever of unknown origin

HIDS:

Hyper IgD syndrome

IPRAFUO:

International Panel for RAre recurrent FUO

LSDs:

Lysosomal storage disorders

MKD:

Mevalonate kinase deficiency

NOMID:

Neonatal onset multisystem inflammatory disease or chronic infantile neurologic, cutaneous, and articular syndrome

PDC:

Potential diagnostic clues

PFAPA:

Periodic fever, aphthous stomatitis, pharyngitis (cervical) adenitis

RFUO:

Recurrent fever of unknown origin

SAA:

Serum amyloid A

TIA:

Transient ischemic attack

TRAPS:

Tumor necrosis factor receptor-1-associated periodic syndrome

References

  1. Petersdorf RG, Beeson PB (1961) Fever of unexplained origin: report on 100 cases. Medicine (Baltimore) 40:1–30

    Article  CAS  Google Scholar 

  2. Durack DT, Street AC (1991) Fever of unknown origin—re-examined and redefined. Curr Clin Top Infect Dis 11:35–51

    CAS  PubMed  Google Scholar 

  3. Knockaert DC, Vanderschueren S, Blockmans D (2003) Fever of unknown origin in adults: 40 years on. J Intern Med 253(3):263–275

    Article  CAS  PubMed  Google Scholar 

  4. Knockaert DC (2007) Recurrent fevers of unknown origin. Infect Dis Clin N Am 21:1189–1211

    Article  Google Scholar 

  5. Knockaert DC, Vanneste LJ, Bobbaers HJ (1993) Recurrent or episodic fever of unknown origin: review of 45 cases and survey of the literature. Medicine 72(3):184–196

    Article  CAS  PubMed  Google Scholar 

  6. Baldovino S, Moliner AM, Taruscio D, Daina E, Roccatello D (2016) Rare diseases in Europe: from a wide to a local perspective. Isr Med Assoc J 18(6):359–363

    PubMed  Google Scholar 

  7. Chao CT, Yang CC, Kao TW (2012) Fabry disease: a rare cause of fever of unknown origin. Am J Kidney Dis 59(1):161–162

    Article  PubMed  Google Scholar 

  8. Marchesoni CL, Roa N, Pardal AM, Neumann P, Cáceres G, Martínez P, Kisinovsky I, Bianchi S, Tarabuso AL, Reisin RC (2010) Misdiagnosis in Fabry disease. J Pediatr 156(5):828–831

    Article  PubMed  Google Scholar 

  9. Lidove O, Kaminsky P, Hachulla E, Leguy-Seguin V, Lavigne C, Marie I, Maillot F, Serratrice C, Masseau A, Chérin P, Cabane J (2012) Noel E; FIMeD investigators. Fabry disease ‘The New Great Imposter’: results of the French Observatoire in Internal Medicine Departments (FIMeD). Clin Genet 81(6):571–577

    Article  CAS  PubMed  Google Scholar 

  10. Verrecchia E, Zampetti A, Antuzzi D, Ricci R, Ferri L, Morrone A, Feliciani C, Dagna L, Manna R (2016) The impact of fever/hyperthermia in the diagnosis of Fabry: a retrospective analysis. Eur J Intern Med 32:26–30

    Article  PubMed  Google Scholar 

  11. Mehta A, Hughes DA (2002) Fabry Disease. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K (eds) GeneReviews® [Internet]. University of Washington, Seattle; 1993–2017 (updated 2017 Jan 5)

  12. Schiffmann R, Ries M (2016) Fabry disease: a disorder of childhood onset. Pediatr Neurol 64:10–20

    Article  PubMed  Google Scholar 

  13. Seydelmann N, Wanner C, Störk S, Ertl G (2015) Weidemann F Fabry disease and the heart. Best Pract Res Clin Endocrinol Metab 29(2):195–204

    Article  CAS  PubMed  Google Scholar 

  14. van der Tol L, Smid BE, Poorthuis BJ, Biegstraaten M, Deprez RH, Linthorst GE et al (2014) A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance. J Med Genet 51:1–9

    Article  PubMed  Google Scholar 

  15. Reisin R, Perrin A, García-Pavía P (2017) Time delays in the diagnosis and treatment of Fabry disease. Int J Clin Pract 71(1). doi:10.1111/ijcp.12914

  16. Thomas AS, Mehta AB (2013) Difficulties and barriers in diagnosing Fabry disease: what can be learnt from the literature? Expert Opin Med Diagn 7(6):589–599

    Article  CAS  PubMed  Google Scholar 

  17. Tabak F, Mert A, Celik AD, Ozaras R, Altiparmak MR, Ozturk R, Aktuglu Y (2003) Fever of unknown origin in Turkey. Infection 31(6):417–420

    CAS  PubMed  Google Scholar 

  18. Bleeker-Rovers CP, Vos FJ, de Kleijn EM, Mudde AH, Dofferhoff TS, Richter C, Smilde TJ, Krabbe PF, Oyen WJ, van der Meer JW (2007) A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore) 86(1):26–38

    Article  Google Scholar 

  19. Nicolotti N, Cattel C, Gualano M, Soriano A, Manna R, Boccia S (2013) A retrospective analysis of 3156 admissions with fever of unknown origin in a large Italian hospital. Epidemiology, Biostatistics and Public Health. (Dicembre): pe8776-1-pe8776-7 (Available at: ebph.it/article/download/8776/8221)

  20. Wolf H, Graninger W (2003) Cost-effectiveness in diagnosis of patients with long-standing fever. Wien Med Wochenschr 153(9–10):202–207

    Article  PubMed  Google Scholar 

  21. Pisani A, Visciano B, Imbriaco M, Di Nuzzi A, Mancini A, Marchetiello C, Riccio E (2014) The kidney in Fabry’s disease. Clin Genet 86(4):301–309

    Article  CAS  PubMed  Google Scholar 

  22. Mignani R, Gallieni M, Feriozzi S, Pisani A, Marziliano N, Morrone A (2015) The nephropathy in the Anderson–Fabry disease: new recommendations for the diagnosis, the follow-up and the therapy. G Ital Nefrol 32(4)

  23. Debette S, Germain DP (2014) Neurologic manifestations of inherited disorders of connective tissue. Handb Clin Neurol 119:565–576

    Article  PubMed  Google Scholar 

  24. Biegstraaten M, Linthorst GE, van Schaik IN, Hollak CE (2013) Fabry disease: a rare cause of neuropathic pain. Curr Pain Headache Rep 17(10):365

    Article  PubMed  Google Scholar 

  25. Davey PG (2014) Fabry disease: a survey of visual and ocular symptoms. Clin Ophthalmol 8:1555–1560

    Article  PubMed  PubMed Central  Google Scholar 

  26. Hagège AA, Germain DP (2015) Adult patients with Fabry disease: what does the cardiologist need to know? Heart 101(12):916–918

    Article  PubMed  Google Scholar 

  27. Zampetti A, Orteu CH, Antuzzi D, Bongiorno MR, Manco S, Gnarra M, Morrone A, Cardinali G, Kovacs D, Aspite N, Linder D, Parini R (2012) Feliciani C; Interdisciplinary Study Group on Fabry Disease (ISGF). Angiokeratoma: decision-making aid for the diagnosis of Fabry disease. Br J Dermatol 166(4):712–720

    Article  CAS  PubMed  Google Scholar 

  28. Germain DP (2010) Fabry disease. Orphanet J Rare Dis 5:30

    Article  PubMed  PubMed Central  Google Scholar 

  29. Morrone A, Cavicchi C, Bardelli T, Antuzzi D, Parini R, Di Rocco M, Feriozzi S, Gabrielli O, Barone R, Pistone G, Spisni C, Ricci R, Zammarchi E (2003) Fabry disease: molecular studies in Italian patients and X inactivation analysis in manifesting carriers. J Med Genet 40(8):e103

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Echevarria L, Benistan K, Toussaint A, Dubourg O, Hagege AA, Eladari D, Jabbour F, Beldjord C, De Mazancourt P, Germain DP (2016) X-chromosome inactivation in female patients with Fabry disease. Clin Genet 89(1):44–54

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors wish to thank Sanofi Genzyme, and particularly Cecilia Traversa, for the support offered in organizing the meeting of the board. The Board coordinator, with Genzyme medical direction, selected the participants based on objective clinical experience criteria and a number of scientific publications related to FUO and Fabry disease in national and international journals.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

RM conceived of the study, and participated in its design and coordination and helped to draft the manuscript. AV participated in the design of study, helped to draft the manuscript and revised it. EV, RC, SF, GG, AG, DL, AM, HO, AP, ER and LD participated in the design of study, and helped to draft the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Raffaele Manna.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of human and animal rights

This article does not contains any study with human participants or animals performed by any of the authors.

Informed consent

None.

Appendix

Appendix

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Manna, R., Cauda, R., Feriozzi, S. et al. Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin. Intern Emerg Med 12, 1059–1067 (2017). https://doi.org/10.1007/s11739-017-1704-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-017-1704-y

Keywords

Navigation